Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

S. J. Jacobus, S. V. Rajkumar, M. Weiss, A. K. Stewart, E. A. Stadtmauer, N. S. Callander, L. M. Dreosti, M. Q. Lacy, R. Fonseca

Research output: Contribution to journalArticlepeer-review

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)e448
JournalBlood cancer journal
Issue number7
StatePublished - Jul 29 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this